Radiation exposure to family caregivers and nurses of pediatric neuroblastoma patients receiving 131I-metaiodobenzylguanidine ( 131I-MIBG) therapy

Clinical Nuclear Medicine

Volumn 38, Issue 8, 2013, Pages 604-607

  Markelewicz, Robert J ^a   Lorenzen, William A ^a   Shusterman, Suzanne ^a   Grant, Frederick D ^a   Fahey, Frederic H ^a   Treves, S Ted ^a  

^a BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

131I metaiodobenzylguanidine; 131I MIBG; exposure; neuroblastoma; radiation; therapy

Indexed keywords

(3 IODOBENZYL)GUANIDINE I 131;

ADOLESCENT; ARTICLE; CAREGIVER; CHILD; CHILDHOOD DISEASE; CLINICAL ARTICLE; CORRELATIONAL STUDY; DOSIMETRY; FAMILY; HUMAN; NEUROBLASTOMA; NURSE; PATIENT CARE; PATIENT SAFETY; PRESCHOOL CHILD; RADIATION DOSE DISTRIBUTION; RADIATION EXPOSURE; RADIATION MEASUREMENT; RADIATION SAFETY; SCHOOL CHILD; WHOLE BODY RADIATION;

3-IODOBENZYLGUANIDINE; ADOLESCENT; CAREGIVERS; CHILD; CHILD, PRESCHOOL; ENVIRONMENTAL EXPOSURE; FEASIBILITY STUDIES; HOSPITALS; HUMANS; NEUROBLASTOMA; NURSES; RADIOTHERAPY DOSAGE; SAFETY; TIME FACTORS;

EID: 84880736509     PISSN: 03639762     EISSN: 15360229     Source Type: Journal    
DOI: 10.1097/RLU.0b013e31829af3c8     Document Type: Article

References (9)

1. Maris JM, Hogarty MD, Bagatell R, et al. Neuroblastoma. Lancet. 2007;369: 2106-2120.
2. Shusterman S, Grant FD, Lorenzen W, et al. Iodine-131-labeled meta-iodobenzylguanidine therapy of children with neuroblastoma: program planning and initial experience. Semin Nucl Med. 2011;41:354-363.
3. Schmidt M, Baum RP, Simon T, et al. Therapeutic nuclear medicine in pediatric malignancy. Q J Nucl Med Mol Imaging. 2010;54:411-428.
4. National Archives and Records Administration. Release of individuals containing unsealed byproduct material or implants containing byproduct material. Code of Federal Regulations. Title 10, Part 35.75, 2011.
5. Marriott CJ, Webber CE, Gulenchyn KY. Radiation exposure for 'caregivers' during high-dose outpatient radioiodine therapy. Radiat Prot Dosimetry. 2007; 123:62-67.
6. Cappelen T, Unhjem JF, Amundsen AL, et al. Radiation exposure to family members of patients with thyrotoxicosis treated with iodine-131. Eur J Nucl Med Mol Imaging. 2006;33:81-86.
7. Barrington SF, O'Doherty MJ, Kettle AG, et al. Radiation exposure of the families of outpatients treated with radioiodine (iodine-131) for hyperthyroid-ism. Eur J Nucl Med. 1999;26:686-692.
8. Monsieurs M, Thierens H, Dierckx RA, et al. Real-life radiation burden to relatives of patients treated with iodine-131: a study in eight centres in Flanders (Belgium). Eur J Nucl Med. 1998;25:1368-1376.
9. Bomanji J, Levison DA, Flatman WD, et al. Uptake of iodine-123 MIBG by pheochromocytomas, paragangliomas, and neuroblastomas: a histopathological comparison. J Nucl Med. 1987;28:973-978.